369 related articles for article (PubMed ID: 19580428)
1. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.
Taneja P; Frazier DP; Kendig RD; Maglic D; Sugiyama T; Kai F; Taneja NK; Inoue K
Expert Rev Mol Diagn; 2009 Jul; 9(5):423-40. PubMed ID: 19580428
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Lawson JS; Tran DD; Ford C; Rawlinson WD
Breast Cancer Res Treat; 2004 Sep; 87(1):13-7. PubMed ID: 15377846
[TBL] [Abstract][Full Text] [Related]
3. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
4. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
5. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
Romieu-Mourez R; Kim DW; Shin SM; Demicco EG; Landesman-Bollag E; Seldin DC; Cardiff RD; Sonenshein GE
Mol Cell Biol; 2003 Aug; 23(16):5738-54. PubMed ID: 12897145
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
7. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
8. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
9. Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer.
Lawson JS; Tran DD; Carpenter E; Ford CE; Rawlinson WD; Whitaker NJ; Delprado W
J Clin Pathol; 2006 Dec; 59(12):1287-92. PubMed ID: 16698952
[TBL] [Abstract][Full Text] [Related]
10. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Notch1 in the development of mouse mammary tumors.
DiƩvart A; Beaulieu N; Jolicoeur P
Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
[TBL] [Abstract][Full Text] [Related]
12. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
[TBL] [Abstract][Full Text] [Related]
13. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
[TBL] [Abstract][Full Text] [Related]
14. Mouse mammary tumor virus-like nucleotide sequences in canine and feline mammary tumors.
Hsu WL; Lin HY; Chiou SS; Chang CC; Wang SP; Lin KH; Chulakasian S; Wong ML; Chang SC
J Clin Microbiol; 2010 Dec; 48(12):4354-62. PubMed ID: 20881168
[TBL] [Abstract][Full Text] [Related]
15. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
16. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
17. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
18. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
[TBL] [Abstract][Full Text] [Related]
19. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
Wang QF; Ding H; Liu BR; Zhang K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]